Niranjan Sardesai

Niranjan Sardesai is a declared insider of Inovio Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). In total, 22 filings cover trades dated from 16 May 2012 to 10 March 2018.

Both buying and selling appear: 4 purchases worth €50k, against 1 sale worth €181k. Taken together, the sales exceed the purchases by €131k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 7 share grants and 10 option exercises.

Half of the purchases are above €13k and half below. Looking at 4 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +18.9%. This is a record of the past, not a forecast.

Most recently, on 13 March 2018, the filings show an option exercise in Inovio Pharmaceuticals, Inc. The last purchase on record was published on 30 September 2015, which is 4,058 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.